Aarkstore.com announce 20% discount on this report Discount till 31st Dec. 2012 - Blepharitis – pipeline review, h2 2012

1. You can also request for sample page of above
mention reports on Customersupport@aarkstore.com

2. Price :
$ 2000 - PDF | $ 4000 - Site Licence | $ 6000 - Corporate Licence
Pages : 40
20% Off on above $ 1000 Reports
25% off on purchase of 2 reports and 30% on purchase of 3 or
more reports.
Discount till 31st Dec. 2012.

3. Summary
Global Markets Direct’s, Blepharitis - Pipeline Review, H2 2012, provides an
overview of the indication’s therapeutic pipeline. This report provides
information on the therapeutic development for Blepharitis, complete with
latest updates, and special features on late-stage and discontinued projects. It
also reviews key players involved in the therapeutic development for
Blepharitis. Blepharitis - Pipeline Review, Half Year is built using data and
information sourced from Global Markets Direct’s proprietary databases,
Company/University websites, SEC filings, investor presentations and featured
press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.

4. Scope
- A snapshot of the global therapeutic scenario for Blepharitis.
- A review of the Blepharitis products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Blepharitis.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.

5. Table Of Contents
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Blepharitis Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Blepharitis 7
Blepharitis Therapeutics under Development by Companies 9
Blepharitis Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Pre-Clinical Stage Products 14
Comparative Analysis 14………………

6. More Related Reports:
http://www.aarkstore.com/publishers/pubreports.asp?PubId=4
9&pagenum=1
Other Ophthalmological Disorders – Pipeline Review, H2 2012
Bacterial Respiratory Tract Infections – Pipeline Review, H2 2012
Allergic Asthma – Pipeline Review, H2 2012
Fibrosis – Pipeline Review, H2 2012
X Chromosome Disorders – Pipeline Review, H2 2012

7. For More details about above & other Reports
plz contact :
Lavanya
Aarkstore.com
Contact: Marketing team
Mob.No.918149852585
Email: enquiry@aarkstore.com
URL: http://www.aarkstore.com
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstore